Looking at top Wall Street opinions, The Gap, Inc. (NYSE: GPS) has recently made its way into the research list of Goldman – signaling that their analyst’s rating adjustment is noteworthy. This stock was downgraded to a rating of Sell in the eyes of Goldman, whereas its previous rating was Neutral in the eyes of Goldman, as reported on Tuesday, January 22nd, 2019. Another heavy-hitting research note was published by Telsey Advisory Group on Wednesday November 21st, 2018, with this firm Reiterated GPS to an updated rating of Outperform. In the past six months and three months of trading, shares of The Gap, Inc. (GPS) have moved by -28.31% and -16.51%, respectively.
Brokerage Updates Related to The Gap, Inc. (GPS) Stock
Of the latest market expert opinions, 4 have given an underperform rating, 0 has given a sell rating, and 1 have given a rating of Buy or better. Based on the 25 stock market experts following this company, the average 12-month price target is $21.11. Moreover, individual price targets range between $15.00-$40.00. With its recent move to $19.00, we can see that these firms project this stock will loss by -45.06% in one year.
Updates from The Gap, Inc. (GPS) SEC Form 4
This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 5.50% rise since the beginning of the calendar year. A President & CEO, Gap at The Gap, Inc. (GPS) sold off some of its shares in a transaction that was finalized on Jun 21. Similarly, Gruber Julie sold 3,286 shares of the organization’s stock at $24.00 apiece and racked up $78,864 in earnings from the sale. Now, Gruber Julie holds 29,099 shares of the company following the exchange. A President & CEO, Old Navy of the organization named Syngal Sonia, was engaged in a transaction that occurred on Mar 07 that managed to be worth $311,871 from the sale of 11,764 common shares at a price of $26.51 per individual share.
The Gap, Inc. (NYSE:GPS) Results in the Pipeline
The next scheduled release of financial results for The Gap, Inc. will be for the Apr-19 quarter. As it stands right now, market analysts are anticipating the per-share earnings for the three-month period will be $0.32. In the same vein, they expect sales for the quarter to amount to $3,773.68 million.
Now let’s turn to earnings surprise history: in the most recent quarter, the company reported about $3,706.00 million in revenue alongside EPS at $0.24. On average, the analyst projection was calling for $4,623.00 million with $0.72 per share in earnings, respectively. In the preceding quarter, this company’s revenue reached $4,089.00 million, with earnings per share ending up at $0.69.
Aurora Cannabis Inc. (NYSE:ACB) experienced a drop of -0.86% from the closing price in the previous trading day.
Pricing Indications for Aurora Cannabis Inc. (ACB)
This organization has had a price-to-earnings ratio of 26.81 in the last year. Meanwhile, it gained 6.88 from its observable 50-day simple moving average. Right at this moment, the per-share value is -20.85% lower than the mean per-share price over the last 200 days in the market.
Aurora Cannabis Inc. (NYSE:ACB) In-Depth Brokerage Insights
We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 0 have a sell rating, 4 have a Buy rating, 4 have an outperform rating, while 5 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 1 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at , based on information from Thomson Reuters.
ACB Stock Value Potential
In trading activity as of late, this stock’s value was 7.31 up from its 200 day moving average, while also -16.29% down when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $7.00-$16.50. The market value for the entire organization reached . In the last trading session, the price ended the day at $5.84. This company’s RSI (Relative Strength Index) managed to hit 37.85.
Aurora Cannabis Inc. (NYSE:ACB) Analyst Points of Focus
Aurora Cannabis Inc. (ACB) has found itself inside of Piper Jaffray’s research list, so their analyst rating adjustment is worth taking note of. This stock was Initiated to Neutral, by Piper Jaffray, as garnered from a news report on Tuesday August 13th, 2019. An additional helpful research note was sent out by BofA/Merrill’s on Thursday July 18th, 2019. The brokerage decided to downgrade ACB to Neutral from its previous rating of Buy.